Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

4
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
4
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of heparin plasma storage at -20 °C or 4 °C on lipoprotein(a) risk stratification.

Clinical chemistry and laboratory medicine·2026
Same author

"Macro transcobalamin causing raised vitamin B12: Case-based laboratory investigation".

Annals of clinical biochemistry·2022
Same author

Two Independent Hematological malignancies in a B-Cell Deficient Good Syndrome Patient.

Rheumatology (Oxford, England)·2020
Same author

A Patient With Multiorgan Failure and Fusiform Rod-Shaped Bacteria in the Blood Smear.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
Same author

Use of Automated Urine Microscopy Analysis in Clinical Diagnosis of Urinary Tract Infection: Defining an Optimal Diagnostic Score in an Academic Medical Center Population.

Journal of clinical microbiology·2018
Same author

Inter-individual variability in phospholipid-dependent interference of C-reactive protein on activated partial thromboplastin time.

British journal of haematology·2017
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

[Thalassaemia diagnostics].

Elske Kusters1, Jean-Louis H Kerkhoffs, André P van Rossum

  • 1Leids Universitair Medisch Centrum, afd. Klinische Chemie en Laboratoriumgeneeskunde, Leiden.

Nederlands Tijdschrift Voor Geneeskunde
|November 13, 2014
PubMed
Summary
This summary is machine-generated.

Thalassaemia carrier status can be identified using routine lab tests like complete blood counts and ferritin levels. Further diagnostics confirm thalassaemia, differentiating it from iron-deficiency anaemia in patients with microcytosis.

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 21, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K

Area of Science:

  • Hematology
  • Medical Diagnostics
  • Genetics

Background:

  • Thalassaemias are inherited blood disorders characterized by reduced or absent globin chain synthesis, leading to abnormal hemoglobin production.
  • They are a significant subgroup of hemoglobinopathies, prevalent in certain ethnic populations.
  • Understanding carrier status is crucial for genetic counseling and reproductive planning.

Observation:

  • The study presents cases of individuals with anemia and microcytosis from Moroccan and Filipino descents.
  • Routine laboratory tests, including complete blood count (CBC) and ferritin levels, were analyzed.
  • These initial tests can suggest thalassaemia carrier status or iron-deficiency anemia.

Findings:

  • Complete blood count and ferritin level measurements can effectively differentiate between iron-deficiency anemia and thalassaemia carrier status.
  • Specific laboratory diagnostic tests are available to confirm or exclude a diagnosis of thalassaemia.
  • The study highlights the utility of routine diagnostics in identifying potential thalassaemia cases.

Implications:

  • Early identification of thalassaemia carrier status through accessible lab tests can improve patient management.
  • Accurate laboratory diagnostics are essential for confirming thalassaemia and guiding treatment.
  • This approach aids in distinguishing thalassaemia from other microcytic anemias, optimizing diagnostic pathways.